skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

81 Total results for product and free and sample content found

Pink Sheet

Zolgensma Data Integrity Fallout

20 Nov 2019

Zolgensma Data Integrity Fallout

Novartis finds itself facing possible criminal or civil action for admitted data manipulation on its application for Zolgensma, a gene therapy used to treat children with spinal muscular atrophy (SMA) – manipulation disclosed only after FDA approval. Pink Sheet was the first to report on the drug’s loss of EU accelerated assessment, nearly 3 weeks before the pharma giant admitted to submitting falsified data to FDA. Follow the scandal and anticipate its implications on the industry with Pink Sheet’s coverage and timeline.

Topic Cell and gene therapy FDA

Meddevicetracker

Drug Delivery Inhalation Devices Report Extract

06 Nov 2019

Drug Delivery Inhalation Devices Report Extract

Capture details about the worldwide market for COPD and asthma inhalation drug devices with Meddevicetracker’s “Drug Delivery: Inhalation Devices Report Extract: US, 5EU Markets, and Japan”.

Generics Bulletin

The US Biosimilars Perspectives

04 Nov 2019

The US Biosimilars Perspectives

As the push to promote the uptake of biosimilars in the US gains more momentum, new opportunities and challenges arise. Keep in tune with important developments in this impactful area using market coverage from Generics Bulletin. 

Topic Biosimilars

Pharma Consulting

Custom Intelligence Biosimilars Report

04 Nov 2019

Custom Intelligence Biosimilars Report

You’ve probably noticed that biosimilars are the growth engine in global medicine spending right now. You’re not alone. With biologics accounting for 20-22% of total pharmaceutical spending already and looking to grow to $320 bn in the US alone by 2023, more and more companies and looking to compete in this arena. Informa’s Biosimilars Insights and Analysis Service can bring you the market intelligence and insights to inform your decisions and help ensure you’re not missing out on opportunities.

Topic Biosimilars

Biomedtracker, Datamonitor Healthcare

2019 Post-ESMO Conference Report Extract

31 Oct 2019

2019 Post-ESMO Conference Report Extract

Tap into insights and highlights from ESMO’s annual meeting of oncology clinicians, researchers, patient advocates, journalists, and members of the pharmaceutical industry.

Topic Cancer Drug development landscape Research

Medtech Insight

Late Stage Medicare Stories Article Pack

25 Oct 2019

Late Stage Medicare Stories Article Pack

Stay aware of key developments and trends in US Medicare and understand their impact on the medtech industry with Medtech Insight. This article pack contains the latest US Medicare updates and late-stage developments.

Topic Medtech

Medtech Insight

New Frontiers for US Medicare Article Pack

25 Oct 2019

New Frontiers for US Medicare Article Pack

Don’t miss a beat with updated coverage of what’s happening with medtech and the US CMS with this article pack. Medtech Insight delivers vital, current news and insights.

Topic Medtech Policy and regulation

Biomedtracker, Meddevicetracker

Q4 2019 Outlook Report Extract

16 Oct 2019

Q4 2019 Outlook Report Extract

What major drug catalysts and events can you expect to see this quarter? Get a view of what's to come with an extract from the full report.

Topic Clinical trials Drug development landscape

Citeline, Pink Sheet

Clinical Trial Design Report

26 Sep 2019

Clinical Trial Design Report

Rising costs, patient recruitment issues, shifting regulations, and more are making bringing new drugs to market more difficult than ever. Explore changes in clinical trial design being adopted in response to these challenges with reporting from Pink Sheet.

Topic Drug development landscape

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: